Blood levels off homocysteine and increased risks of cardiovascular disease - Causal of casual?

Citation
Wg. Christen et al., Blood levels off homocysteine and increased risks of cardiovascular disease - Causal of casual?, ARCH IN MED, 160(4), 2000, pp. 422-434
Citations number
102
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
ARCHIVES OF INTERNAL MEDICINE
ISSN journal
00039926 → ACNP
Volume
160
Issue
4
Year of publication
2000
Pages
422 - 434
Database
ISI
SICI code
0003-9926(20000228)160:4<422:BLOHAI>2.0.ZU;2-Y
Abstract
Background: Accumulating data from epidemiological studies suggest that ind ividuals with elevated blood levels of homocysteine have increased risks of cardiovascular disease. We reviewed the currently available evidence of an association between homocysteine and cardiovascular disease and examined w hether the strength of the evidence Varies according to study design. Methods: We used a computerized MEDLINE literature search, 1966 through Sep tember 1998, to identify all epidemiological studies that examined the rela tionship of homocysteine level with risks of coronary heart or cerebrovascu lar disease. Two measures of plasma homocysteine level and its association with risk of cardiovascular disease were extracted: mean homocysteine level in cases and controls, and relative risk of cardiovascular disease for ele vated homocysteine level. Results: A total of 43 studies were reviewed. Most cross-sectional and case -control studies indicated higher mean homocysteine levels (either fasting or after methionine load) and/or a greater frequency of elevated homocystei ne level in persons with cardiovascular disease as compared with persons wi thout cardiovascular disease. Results of most prospective studies, however, indicated smaller or no association. The few prospective studies that repo rted a positive association between homocysteine level and risks of cardiov ascular disease included patients with preexisting vascular disease. Conclusions: In contrast to cross-sectional and case-control studies, resul ts of prospective studies indicated less or no predictive ability for plasm a homocysteine in cardiovascular disease. Instead, elevated homocysteine le vel may be an acute-phase reactant that is predominantly a marker of athero genesis, or a consequence of other factors more closely linked to risks of cardiovascular disease. Randomized trials are necessary to test reliably wh ether lowering homocysteine levels will decrease risks of cardiovascular di sease.